A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore (NTU Singapore), University of Malaya, University of Cambridge, A*STAR's Genome Institute of Singapore (GIS) and other institutions, have conducted the largest study done to date of BRCA1 and BRCA2 (BReast CAncer Gene 1 and 2) carriers in an Asian population and refined breast and ovarian cancer risk estimates for this population.

Related Keywords

Singapore , Malaysia , Cambridge , Cambridgeshire , United Kingdom , Nanyang , Henan , China , United States , Nottingham , Chinese , Malaysian , Malaya , America , Singaporean , Joanne Ngeow , Singapore Lee Kong Chian School Of Medicine , National Comprehensive Cancer Network , Lancet Regional Health , University Of Malaya , University Of Cambridge , National Cancer Centre Singapore , Singapore National Precision Medicine Programme , Genome Institute Of Singapore , Cancer Research Malaysia , University Of Nottingham Malaysia , Head Of The Cancer Genetics Service , Nanyang Technological University , National Precision Medicine Programme , Malaysian Chinese , Singaporean Chinese , Malaysian Indians , Singaporean Indians , East Asians , South Asians , North America , Co Senior Author , Associate Professor , Genomic Medicine , Lee Kong Chian School , Cancer Genetics Service , Singapore Ministry , National Medical Research Council , Clinician Scientist Award ,